Senior Global Medical Manager Immuno-Oncology (m/w/d)

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com The Position As Senior Global Medical Manager Immuno-Oncology, you will contribute scientific and medical leadership to the global medical strategy for an early oncology brand. Reporting to the Brand Head Immuno-Oncology, you will be accountable for defined medical deliverables that prepare the asset and healthcare ecosystem for future clinical adoption and patient access. Working in a global matrix, including close collaboration with the Pipeline Medical Affairs Lead, you will translate scientific evidence, external insights and unmet needs into focused medical strategies, evidence-generation plans and measurable outcomes that help close relevant care gaps. Tasks & responsibilities Contribute to the development and continuous refinement of the global medical strategy, translating strategic priorities, unmet needs and care gaps into clearly defined medical deliverables and outcome measures. Take end-to-end accountability for the strategic direction, quality and timely delivery of major medical deliverables. These include Medical Affairs-led evidence generation, scientific communication and publications, external expert engagement, patient-journey and care-gap analysis, and medical launch preparation. Shape and drive Medical Affairs-led evidence generation within the Integrated Evidence Plan, including investigator-initiated studies, Phase IIIb/IV studies, real-world evidence and other fit-for-purpose approaches that address decision-relevant evidence gaps and support future clinical practice. Lead medical launch preparation for assigned areas by defining the scientific narrative, building organizational and country readiness, anticipating evidence and education needs, and supporting the conditions required for appropriate clinical adoption and patient access. Build trusted scientific relationships with international experts, societies, research networks and other stakeholders across the healthcare ecosystem, translating external insights into strategic recommendations, evidence priorities and medical action. Provide medical leadership across global, regional and cross-functional teams, working closely with the Pipeline Medical Affairs Lead and partners in Clinical Development, Regulatory Affairs, Market Access, Commercial and country Medical Affairs to ensure strategic alignment and high-quality execution. Requirements Advanced degree in medicine or life sciences (MD, PhD, PharmD or equivalent) and long-term experience in Medical Affairs within the pharmaceutical industry with global and regional/ local responsibility. Mandatory, substantial experience in immuno-oncology and non-small cell lung cancer (NSCLC), supported by an in-depth understanding of the scientific and clinical landscape, evolving treatment paradigms, unmet needs and barriers across the patient journey. Experience in colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC) and/or breast cancer is highly desirable. Proven experience contributing to global medical strategy and leading complex medical workstreams for oncology assets, including medical launch preparation or indication expansion. Demonstrated track record in shaping and delivering Medical Affairs-led evidence generation, including the identification and prioritization of evidence gaps, development of study concepts, oversight of study delivery and translation of results into decisio